ArticleCureus2026
Bulbar Onset Generalized Myasthenia Gravis in an Elderly Patient: A Diagnostic Challenge.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myasthenia gravis (MG) can present with variable and atypical symptoms, particularly in older adults, where isolated bulbar involvement may mimic stroke or motor neuron disease. We report a case of an elderly patient with late-onset, acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis who initially presented with ptosis, followed by progressive dysphagia and dysarthria, and subsequently developed head drop. Electromyography (EMG) confirmed a neuromuscular junction disorder, and serology demonstrated markedly elevated AChR antibodies. Early initiation of pyridostigmine and corticosteroids led to rapid clinical improvement, with the Myasthenia Gravis Activities of Daily Living (MG-ADL) score decreasing from 11/24 to 0/24 within three weeks. This case highlights the importance of considering MG in elderly patients presenting with isolated bulbar symptoms and demonstrates the diagnostic value of electrophysiology and antibody testing for timely treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.